Even though IL-33 has not been investigated as a mediator in a group suffering from these two co-morbid diseases, it can be hypothesized that this alarmin enhances airway remodeling and fibrosis occurring in the course of asthma due to its increased level caused by co-morbid OSA. Here, IL33 is linked to obstructive sleep apnea syndrome.